Activated VEGF Receptor Shed Into the Vitreous in Eyes With Wet AMD A New Class of Biomarkers in the Vitreous With Potential for Predicting the Treatment Timing and Monitoring Response
Activated VEGF Receptor Shed Into the Vitreous in Eyes With Wet AMD A New Class of Biomarkers in the Vitreous With Potential for Predicting the Treatment Timing and Monitoring Response
复制标题
DOI:
10.1001/archophthalmol.2009.88
复制
发表时间:
2009-05-01
影响因子:
--
通讯作者:
Glaser, Bert M.
中科院分区:
文献类型:
--
作者:
Davuluri, Geetanjali;Espina, Virginia;Glaser, Bert M.
Objective: To examine whether phosphorylated vascular endothelial growth factor (VEGF) receptors shed into the vitreous reflect the ongoing retinal and choroidal signal pathway activity in wet age-related macular degeneration (AMD).Methods: Vitreous samples obtained immediately prior to anti-VEGF injection from 11 patients with choroidal neovascularization were analyzed using reverse-phase microarrays. Two patients had samples collected at the time of injection and 1 month later. Samples from 5 patients were collected prior to vitrectomy for macular hole, epiretinal membrane, or retinal detachment.Results: Phosphorylated forms of VEGF receptor (VEGFR Y996 and Y1175), platelet-derived growth factor receptor beta (PDGFR beta Y716 and Y751), and c-KIT (Y703) were present in the Vitreous. A significant difference in PDGFR beta Y751 (P